Small‑molecule drug discovery focuses on relatively low‑molecular‑weight compounds that can usually be formulated as oral tablets or simple injectables. These drugs often target enzymes, receptors, or other proteins. For healthcare leaders, distinguishing small‑molecule discovery from biologics or cell therapies clarifies what kinds of treatments a given AI platform is likely to generate and how they fit into existing therapeutic categories.